Preterm birth risk assessment

J G Mauldin1, R B Newman

  • 1Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston 29425, USA.

Seminars in Perinatology
|September 20, 2001
PubMed

Insights

Preventing preterm birth remains a challenge, as rates have increased despite tocolytic use. While fetal fibronectin and ultrasound are effective, home uterine monitoring has not proven beneficial for reducing preterm birth.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Maternal-Fetal Medicine

Background:

  • Preterm birth is a primary cause of infant morbidity and mortality, with national rates near 11%.
  • Despite extensive use of tocolytic agents, the incidence of preterm birth has risen in the U.S. over the last three decades.
  • The etiology of preterm birth is multifactorial, involving potential insults to the uteroplacental barrier, fetal stress pathways, cervical incompetence, and uterine distention.

Purpose of the Study:

  • To review biochemical and biophysical markers for identifying women at risk of preterm delivery.
  • To evaluate the efficacy of various predictive methods in managing and preventing preterm birth.

Main Methods:

  • Review of existing studies on biochemical markers (e.g., fetal fibronectin, salivary estriol).
  • Analysis of biophysical markers, specifically endovaginal ultrasound assessment of cervical length.
  • Evaluation of home uterine activity monitoring systems.

Main Results:

  • Fetal fibronectin assays and endovaginal ultrasound are effective in identifying symptomatic women at low risk for preterm birth.
  • Salivary estriol shows promise as a reliable risk identifier in high-risk populations.
  • Home uterine activity monitoring has not demonstrated a reduction in preterm birth frequency or associated neonatal complications.

Conclusions:

  • Certain markers, like fetal fibronectin and cervical ultrasound, are valuable tools for risk stratification in preterm birth prediction.
  • Further research is needed for markers such as salivary estriol to confirm their role in clinical practice.
  • Current evidence does not support the use of home uterine activity monitoring for preventing preterm birth.

Related Concept Videos

Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Assessment of Respiration01:23

Assessment of Respiration

The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...